Erol R Akdamar
CIK 1957739 · View on SEC EDGAR ↗
First SEC filing: Jan. 11, 2023 · Latest: Jan. 11, 2023
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Nov. 14, 2024 | HCA | S | 2,900 | $353.00 | $1,023,700 | 6,843 Direct | -29.76% | Disposed | 17.8% (price as of 2026-08-21) |
| April 28, 2023 | HCA | S | 3,500 | $285.00 | $997,500 | 42,484 Direct | -7.61% | Disposed | 45.9% (price as of 2026-08-21) |
| Feb. 2, 2023 | HCA | S | 3,000 | $258.63 | $775,890 | 34,726 Direct | -7.95% | Disposed | 60.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Nov. 12, 2024 | HCA | Stock Appreciation Right | Common Stock (20,000) | $68.96 | Feb. 4, 2025 | 20,000 | Disposed |
| Jan. 31, 2024 | HCA | Stock Appreciation Right | Common Stock (11,005) | $304.90 | Jan. 31, 2034 | 11,005 | Acquired |
| Nov. 13, 2023 | HCA | Stock Appreciation Right | Common Stock (12,325) | $47.97 | Feb. 5, 2024 | 12,325 | Disposed |
| Nov. 13, 2023 | HCA | Stock Appreciation Right | Common Stock (14,500) | $47.97 | Feb. 5, 2024 | 14,500 | Disposed |
| Feb. 3, 2023 | HCA | Stock Appreciation Right | Common Stock (9,000) | $45.30 | Nov. 6, 2023 | 9,000 | Disposed |
| Jan. 30, 2023 | HCA | Stock Appreciation Right | Common Stock (17,051) | $253.30 | Jan. 30, 2033 | 17,051 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 13 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Jan. 11, 2023 | HCA | Common Stock | 37,726 | Direct |
| Jan. 11, 2023 | HCA | Common Stock | 60,000 | Indirect |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (9,000) | 9,000 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (14,500) | 14,500 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (12,325) | 12,325 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (20,000) | 20,000 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (16,440) | 16,440 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (17,430) | 17,430 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (25,160) | 25,160 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (14,670) | 14,670 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (16,910) | 16,910 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (12,820) | 12,820 | Direct |
| Jan. 11, 2023 | HCA | Stock Appreciation Right→ Common Stock (8,490) | 8,490 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $785,000 | — | — | — | $1,304,371 | — | $390,017 | $5,400,861 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.